# Angioplasty Balloons Market > Angioplasty Balloons Market Research Report: Size, Share, Trend Analysis By Types (Drug-Eluting Balloons, Plain Old Balloons, Scoring Balloons), By Applications (Coronary Angioplasty, Peripheral Angioplasty, Renal Angioplasty), By Material (Polymer, Latex, Metal), By End Use (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 3.81% - **2024:** $ 3.38 Billion - **2025:** $ 3.51 Billion - **2035:** $ 5.1 Billion - **Key Players:** Boston Scientific (US), Medtronic(US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cordis (US), Terumo Corporation (JP), Asahi Intecc Co., Ltd. (JP), Cook Medical (US), AngioDynamics (US) **Report ID:** MRFR/HC/8136-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/angioplasty-balloons-market-9614 --- ## Market Summary ## **Global Angioplasty Balloons Market Overview** As per MRFR analysis, the Angioplasty Balloons Market Size was estimated at 3.25 (USD Billion) in 2023. The Angioplasty Balloons Market Industry is expected to grow from 3.38(USD Billion) in 2024 to 5.1 (USD Billion) by 2035. The Angioplasty Balloons Market CAGR (growth rate) is expected to be around 3.81% during the forecast period (2025 - 2035). **Key Angioplasty Balloons Market Trends Highlighted** The Angioplasty Balloons Market is currently undergoing substantial market trends, which are primarily driven by the rise in the prevalence of cardiovascular diseases among the general population. There is a growing demand for effective treatment options due to the increase in geriatric demographics and lifestyle-related health issues, which are key market drivers. The emphasis on minimally invasive procedures is promoting innovation in balloon technology, which has resulted in angioplasty being the preferable option among healthcare providers. Additionally, the efficacy of these balloons is being improved by improvements in materials and coatings, which are resulting in safer procedures and improved patient outcomes. Opportunity is emerging as a result of the increasing awareness of cardiac health and the availability of a variety of initiatives by health organizations that promote regular screenings. The objective of these initiatives is to decrease the mortality rates associated with cardiac diseases, thereby increasing the market for angioplasty balloons. Furthermore, the market participants are presented with a substantial opportunity to capitalize on the expansion of healthcare infrastructure and the enhanced accessibility of medical services in developing regions. Recent trends suggest that there is a growing preference for biodegradable and drug-eluting balloons, which are gaining popularity due to their capacity to enhance healing outcomes and reduce the risk of restenosis. Additionally, the efficacy and safety of interventional procedures are being improved through the incorporation of advanced imaging technologies. The demand for advanced angioplasty balloons is anticipated to increase as hospitals and clinics adjust to these innovations. The evolution of this market is ultimately influenced by the imperative need to address the growing global burden of cardiovascular ailments and the ongoing technological advancements. **Angioplasty Balloons Market Drivers** **Increase in Cardiovascular Diseases** The rise in the prevalence of cardiovascular diseases (CVDs) globally is a significant driver for the growth of the Angioplasty Balloons Market Industry. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide, claiming approximately 17.9 million lives each year, which equates to 31% of all global deaths. This alarming statistic underscores the increasing demand for effective medical interventions like angioplasty, which utilizes specialized balloons to clear blockages in the arteries. Organizations such as the American Heart Association are actively promoting awareness and research initiatives to combat CVDs, thereby fostering a supportive market environment for angioplasty balloon manufacturers. The rising number of procedures performed to address CVDs contributes to the anticipated market growth, as more patients turn to angioplasty as a means of restoring healthy blood flow. **Technological Advancements in Devices** Technological innovations in angioplasty balloons are shaping the future of the Angioplasty Balloons Market Industry significantly. The introduction of drug-eluting balloon catheters, which deliver medication directly to the arterial lining to prevent restenosis, has revolutionized the treatment methods available. A report from the U.S. Food and Drug Administration (FDA) indicates that these advancements have increased the efficacy rates of angioplasty procedures, drawing more healthcare providers to adopt these advanced technologies. Major medical device companies, including Medtronic and Boston Scientific, are investing heavily in Research and Development to enhance balloon design and performance, which is expected to drive market growth as healthcare adoption of such sophisticated devices increases globally. **Growing Aging Population** The global aging population is another key driver of growth in the Angioplasty Balloons Market Industry, as older individuals are more susceptible to cardiovascular issues. The United Nations reports that the global population aged 60 and above is projected to reach 2.1 billion by 2050, resulting in a greater demand for healthcare services, particularly cardiovascular interventions such as angioplasty. This demographic shift emphasizes the need for effective treatment solutions, thus propelling the market for angioplasty balloons. Additionally, established organizations like the International Federation on Ageing are advocating for improved healthcare strategies to cater to the unique medical needs of the elderly, further enhancing the market landscape for angioplasty balloon manufacturers. **Angioplasty Balloons Market Segment Insights** **Angioplasty Balloons Market Type Insights** The Angioplasty Balloons Market, as part of a broader healthcare landscape, showcases significant growth across various types, namely Drug-Eluting Balloons, Plain Old Balloons, and Scoring Balloons. By 2024, the market is set to reveal a valuation of 3.38 USD Billion, with Drug-Eluting Balloons contributing 1.5 USD Billion to this total, thereby showcasing the dominant role that this type plays due to its efficacy in delivering medication directly to the artery wall during the angioplasty procedure, which enhances patient outcomes and reduces restenosis rates. In contrast, Plain Old Balloons are projected to generate 1.2 USD Billion. This type remains a reliable choice in cases where pharmacological treatments are not indicated, making up a significant portion of procedures and appealing to cost-sensitive healthcare systems. Scoring Balloons, while relatively less prominent, with a valuation of 0.68 USD Billion, offer a niche application for lesion dilation and benefit from the ability to modify the arterial wall without leaving a permanent implant, attracting attention for complex coronary interventions. As the Angioplasty Balloons Market continues to evolve, the increasing prevalence of cardiovascular diseases and the ongoing innovations in balloon technology further drive the expansion of these segments, emphasizing their importance in addressing patient needs and preferences. The overall market dynamics indicate a robust growth trajectory, with the Drug-Eluting Balloons segment holding the majority share, underscoring its critical role in modern interventional cardiology. The projected increase to 5.1 USD Billion by 2035 highlights the growing demand for effective treatment options in this space, with Drug-Eluting Balloons expected to effectively respond to this trend, fostering improved healthcare outcomes for a global population with escalating cardiovascular complications. The market statistics reflect a clear segmentation, which sheds light on the significant opportunities for growth in each type, particularly as technological advancements lead to improved performance and patient outcomes. **Angioplasty Balloons Market Application Insights** The Angioplasty Balloons Market is poised for significant growth, with a projected market valuation of USD 3.38 Billion in 2024. This market is segmented into various applications, namely Coronary Angioplasty, Peripheral Angioplasty, and Renal Angioplasty, each contributing to the overall market landscape. Coronary Angioplasty, addressing one of the most prevalent cardiovascular conditions, significantly drives demand due to the increasing prevalence of coronary artery disease globally. Peripheral Angioplasty also plays a crucial role in treating peripheral arterial diseases, which have been on the rise due to factors like obesity and diabetes. Renal Angioplasty serves a more niche but vital need, targeting renal artery stenosis and its related complications. The overall market encompasses these varied applications, with growing global awareness of vascular conditions contributing to increases in procedures, thereby boosting the Angioplasty Balloons Market revenue. As healthcare technology advances and the aging population expands, the dynamics around these applications reflect important trends driven by necessity and innovation, leading to continuous market growth and significant opportunities across the Angioplasty Balloons Market industry. **Angioplasty Balloons Market Material Insights** The Angioplasty Balloons Market focuses on materials such as Polymer, Latex, and Metal, which play crucial roles in the effectiveness of angioplasty procedures. By 2024, the entire market is expected to be valued at 3.38 billion USD, underscoring the importance of innovation and material quality in this field. In particular, polymer-based balloons are gaining traction due to their flexibility and durability, which enhance performance during procedures. Latex materials, while historically significant, face challenges related to allergies, necessitating a gradual shift toward alternatives. Metal balloons, though less common, offer robustness, especially in complex cases. The growth of the Angioplasty Balloons Market is driven by an increasing aging population and rising incidences of cardiovascular disorders. Additionally, advancements in manufacturing techniques are expected to bolster the development of more efficient and tailored balloon materials. However, challenges such as regulatory compliance and material compatibility must be addressed to fully leverage opportunities in the market. Overall, understanding the materials in the Angioplasty Balloons Market is essential for developing effective treatment solutions, ultimately leading to improved patient outcomes. **Angioplasty Balloons Market End Use Insights** The Angioplasty Balloons Market is witnessing significant expansion within its End Use segment, which includes Hospitals, Ambulatory Surgical Centers, and Cardiac Catheterization Laboratories. By 2024, the market is projected to be valued at 3.38 USD Billion, driven by increasing cardiovascular diseases and the rising number of procedures involving angioplasty balloons. Hospitals play a crucial role, as they provide comprehensive care utilizing advanced technology and skilled professionals, thereby dominating this market segment. Ambulatory Surgical Centers, recognized for their cost-effectiveness and efficiency in conducting outpatient procedures, are also gaining prominence, reflecting evolving healthcare delivery systems. Cardiac Catheterization Laboratories are essential as they specialize in diagnostics and interventional procedures, playing a vital role in improving patient outcomes. The Angioplasty Balloons Market data highlights a trend towards minimally invasive surgeries, further propelling market growth. The increase in lifestyle-related health issues and the growing elderly population serve as substantial growth drivers. However, challenges such as regulatory hurdles and high costs of advanced technology continue to pose constraints. The market is also poised to benefit from technological advancements and increasing healthcare expenditure globally, creating new opportunities within this segment. **Angioplasty Balloons Market Regional Insights** The Angioplasty Balloons Market exhibits a diverse landscape across its regional segments. In 2024, the market is valued at approximately 3.38 USD Billion, with North America dominating this space at 1.45 USD Billion, reflecting a significant majority holding. This region is anticipated to maintain its leadership into 2035 with a valuation of 2.15 USD Billion, driven by advanced healthcare infrastructure and high adoption of minimally invasive surgeries. Europe follows as a notable segment, valued at 0.85 USD Billion in 2024 and projected to reach 1.25 USD Billion by 2035, benefiting from increasing cardiovascular disease prevalence and growing awareness regarding angioplasty procedures. The Asia Pacific region, holding a value of 0.75 USD Billion in 2024 and projected to grow to 1.15 USD Billion in 2035, shows promising potential due to rising urbanization and improving healthcare access. South America is positioned at a value of 0.3 USD Billion in 2024 and is expected to grow to 0.45 USD Billion by 2035, indicating gradual adoption of angioplasty procedures amidst evolving healthcare policies. The Middle East and Africa segment, while smaller at 0.03 USD Billion in 2024, is projected to grow to 0.1 USD Billion by 2035, reflecting burgeoning healthcare reforms and service improvements. Overall, these regional insights illustrate a robust growth trajectory within the Angioplasty Balloons Market, emphasizing the importance of localized healthcare advancements and patient accessibility across various regions. **Angioplasty Balloons Market Key Players and Competitive Insights** The Angioplasty Balloons Market is characterized by intense competition among various manufacturers and suppliers that strive to innovate and expand their offerings. The market encompasses a wide range of products designed for different types of angioplasty procedures, including drug-coated balloons and plain balloons. Companies in this space are focused on enhancing product efficacy and safety while reducing risks associated with coronary and peripheral artery diseases. The competitive landscape is shaped by factors such as technological advancements, product innovations, strategic partnerships, regulatory approvals, and the ability to cater to diverse patient needs globally. As the prevalence of cardiovascular diseases continues to rise, the demand for advanced angioplasty solutions drives the competition further, pushing companies to invest significantly in research and development for sustainable growth. Asahi Intecc has established a strong presence within the Angioplasty Balloons Market, leveraging its cutting-edge technology and manufacturing capabilities. The company's commitment to innovation is evident in its portfolio, which includes high-quality, reliable angioplasty balloons designed for optimal performance in various clinical situations. Asahi Intecc has effectively positioned itself through partnerships and collaborations, enhancing its distribution network and market penetration across different regions. By maintaining high-quality standards and focusing on customer satisfaction, Asahi Intecc has gained recognition among healthcare professionals and patients alike. The company's expertise in minimally invasive techniques also adds to its competitive edge, enabling rapid adoption of its products in diverse clinical settings worldwide. Philips Healthcare is a significant player in the Angioplasty Balloons Market, known for its comprehensive range of advanced medical devices and healthcare solutions. The company focuses on developing innovative angioplasty balloon technologies, including specialized drug-coated options that provide enhanced therapeutic benefits. Philips Healthcare's extensive market presence is supported by its strong global distribution network and dedication to research and development, which drives continuous product improvements. The company frequently engages in strategic collaborations, mergers, and acquisitions to bolster its capabilities and expand its portfolio. Philips Healthcare’s commitment to quality assurance and patient safety further solidifies its reputation in the market. By emphasizing customer-centric solutions and pioneering cutting-edge technologies, Philips Healthcare aims to meet the evolving needs of the healthcare landscape globally. **Key Companies in the Angioplasty Balloons Market Include** - Asahi Intecc - Philips Healthcare - Smith & Nephew - Cook Medical - Medtronic Cardiovascular - Medtronic - Terumo Cardiovascular Group - Spectranetics - Cardinal Health - Braun Melsungen - Terumo Corporation - Johnson & Johnson - Cordis Corporation - Abbott Laboratories - Boston Scientific **Angioplasty Balloons Market Industry Developments** Recent developments in the Angioplasty Balloons Market indicate a significant increase in demand driven by the rise in cardiovascular diseases globally. Companies like Medtronic Cardiovascular and Boston Scientific have been focusing on enhancing their product offerings to include advanced balloon technologies that improve patient outcomes. Notably, in September 2023, Abbott Laboratories announced the launch of a new line of drug-eluting balloons, aimed at providing more effective treatment options for patients suffering from coronary artery disease. Furthermore, a strategic merger was confirmed in August 2023, where Philips Healthcare acquired a small biotechnology firm specializing in innovative angioplasty balloon technologies, thereby augmenting its portfolio. Meanwhile, Asahi Intecc reported a steady growth in market valuation due to the increasing adoption of minimally invasive procedures, reflecting a broader industry trend aligning with healthcare advancements. In recent years, significant investments led by Johnson and Johnson and Cook Medical into Research and Development activities have aimed to drive innovation in angioplasty balloon designs, contributing to the overall market growth. These advancements and corporate strategies highlight the evolving landscape of the Angioplasty Balloons Market as companies look to capture market share through technological improvements and strategic collaborations. **Angioplasty Balloons Market Segmentation Insights** - **Angioplasty Balloons Market Type Outlook** - Drug-Eluting Balloons - Plain Old Balloons - Scoring Balloons - **Angioplasty Balloons Market Application Outlook** - Coronary Angioplasty - Peripheral Angioplasty - Renal Angioplasty - **Angioplasty Balloons Market Material Outlook** - Polymer - Latex - Metal - **Angioplasty Balloons Market End Use Outlook** - Hospitals - Ambulatory Surgical Centers - Cardiac Catheterization Laboratories - **Angioplasty Balloons Market Regional Outlook** - North America - Europe - South America - Asia Pacific - Middle East and Africa ## Market Drivers ### Regulatory Influence on Market Dynamics Regulatory frameworks play a crucial role in shaping the Angioplasty Balloons Market. Stringent regulations ensure the safety and efficacy of medical devices, including angioplasty balloons. Compliance with these regulations can be a double-edged sword; while they may pose challenges for manufacturers, they also foster innovation and quality improvements. Regulatory bodies are increasingly focusing on post-market surveillance and real-world evidence, which can influence product development and market entry strategies. As companies navigate these regulatory landscapes, the Angioplasty Balloons Market is likely to evolve, with an emphasis on transparency and patient safety. This dynamic environment may lead to the introduction of new products that meet regulatory standards. ### Rising Prevalence of Cardiovascular Diseases The increasing incidence of cardiovascular diseases is a primary driver for the Angioplasty Balloons Market. As populations age and lifestyle-related health issues become more prevalent, the demand for effective treatment options rises. Statistics indicate that cardiovascular diseases remain a leading cause of mortality worldwide, prompting healthcare systems to seek innovative solutions. Angioplasty procedures, facilitated by advanced balloon technologies, are becoming a standard treatment for conditions such as coronary artery disease. This growing patient population necessitates a robust supply of angioplasty balloons, thereby propelling market growth. The Angioplasty Balloons Market is thus positioned to expand as healthcare providers respond to this urgent need. ### Growing Investment in Healthcare Infrastructure Investment in healthcare infrastructure is a significant driver for the Angioplasty Balloons Market. As countries prioritize healthcare improvements, the establishment of advanced medical facilities and the procurement of cutting-edge medical devices become essential. Increased funding for cardiovascular care, particularly in emerging markets, is expected to enhance access to angioplasty procedures. This trend is supported by government initiatives aimed at reducing the burden of cardiovascular diseases. Consequently, the demand for angioplasty balloons is anticipated to rise, as healthcare providers seek to equip their facilities with the latest technologies. The Angioplasty Balloons Market stands to benefit from this influx of investment, potentially leading to enhanced patient care. ### Technological Advancements in Angioplasty Balloons The Angioplasty Balloons Market is experiencing a notable transformation due to rapid technological advancements. Innovations such as drug-eluting balloons and bioresorbable materials are enhancing the efficacy of angioplasty procedures. These advancements not only improve patient outcomes but also reduce the risk of restenosis, a common complication. The introduction of advanced imaging techniques and minimally invasive procedures is further driving the adoption of angioplasty balloons. According to recent data, the market for drug-eluting balloons is projected to grow significantly, indicating a shift towards more effective treatment options. As healthcare providers increasingly adopt these technologies, the Angioplasty Balloons Market is likely to witness substantial growth in the coming years. ### Increasing Awareness and Education on Cardiovascular Health The growing awareness and education surrounding cardiovascular health are pivotal for the Angioplasty Balloons Market. Public health campaigns and educational initiatives are informing populations about the risks associated with cardiovascular diseases and the importance of early intervention. As individuals become more knowledgeable about treatment options, including angioplasty, the demand for these procedures is likely to increase. Healthcare providers are also focusing on patient education, which can lead to higher rates of diagnosis and treatment. This heightened awareness is expected to drive the adoption of angioplasty balloons, as patients seek effective solutions for their cardiovascular issues. The Angioplasty Balloons Market is thus poised for growth as awareness continues to expand. ## Future Outlook The Angioplasty Balloons Market is projected to grow at a 3.81% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures. **New opportunities:** - Development of biodegradable angioplasty balloons for enhanced patient safety. Expansion into emerging markets with tailored product offerings. Integration of smart technology for real-time monitoring during procedures. By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs. ## Segment Insights ### By Type: Drug-Eluting Balloons (Largest) vs. Scoring Balloons (Fastest-Growing) In the Angioplasty Balloons Market, Drug-Eluting Balloons, which is one of the crucial angioplasty balloon types, command a significant share due to their ability to deliver medication directly to the affected area, thereby reducing the risk of restenosis. Plain Old Balloons, while being a standard choice, cater to a specific segment of patients who may not require advanced therapy. Scoring Balloons are gradually carving out their niche with their ability to provide enhanced vessel modifications, thus complementing the existing offerings in this market. Drug-Eluting Balloons (Dominant) vs. Scoring Balloons (Emerging) Drug-Eluting Balloons hold a dominant position in the [Angioplasty](https://www.marketresearchfuture.com/reports/angioplasty-balloons-market-9614)Balloons Market due to their unique design that combines angioplasty with localized drug therapy. This has proven effective in reducing restenosis rates, making them a preferred choice among cardiologists. In contrast, Scoring Balloons are an emerging solution that provides mechanical help to opened vessels and encourage positive remodeling of the arteries. Their growth is driven by increasing procedural volume and the need for innovative technologies that ensure patient safety and efficacy, positioning them as a promising alternative to traditional options. ### By Application: Coronary Angioplasty (Largest) vs. Peripheral Angioplasty (Fastest-Growing) In the Angioplasty Balloons Market, the application segment is prominently dominated by coronary angioplasty. This segment holds the majority market share due to the high prevalence of coronary artery diseases and the increasing number of angioplasty procedures globally. Peripheral angioplasty follows closely, showing significant growth as healthcare providers focus on treating peripheral artery diseases, which have become increasingly recognized and treated in recent years. Coronary Angioplasty (Dominant) vs. Peripheral Angioplasty (Emerging) Coronary angioplasty remains the dominant segment in the Angioplasty Balloons Market, primarily because of its established use and effectiveness in treating coronary artery blockages. It is widely favored among healthcare professionals and patients for its proven success rates. On the other hand, peripheral angioplasty is an emerging segment that has gained traction due to the rising incidence of peripheral artery disease (PAD). This segment is expected to witness robust growth driven by advancements in balloon technology and increasing awareness about the treatment options available for chronic limb ischemia. The increasing patient population and the need for minimally invasive procedures further support the expansion of this segment. ### By Material: Polymer (Largest) vs. Metal (Fastest-Growing) In the Angioplasty Balloons Market, the angioplasty balloon material segment showcases a diverse range of options, with polymers leading the share distribution. Polymeric balloons are favored for their flexibility and compliance, making them ideal for various angioplasty procedures. They account for a significant portion of market usage, offering a superior balance of performance and patient safety. On the other hand, metal balloons, although smaller in market share, are gaining traction due to their robustness and ability to maintain shape under high-pressure conditions, making them suitable for specific clinical applications. The growth trends indicate a pronounced shift towards polymer materials, driven by technological advancements and increasing demand for minimally invasive procedures. Furthermore, the market for metal balloons is rapidly expanding as they are recognized for their durability and efficacy in challenging anatomical circumstances. As healthcare providers continue to prioritize patient outcomes, the development of advanced polymer formulations and metal balloon designs is expected to accelerate, shaping the competitive landscape of the Angioplasty Balloons Market.Regional Insights Polymer (Dominant) vs. Metal (Emerging) Polymer balloons dominate the Angioplasty Balloons Market due to their excellent performance characteristics, including flexibility, compliance, and safety. These attributes enable them to effectively navigate the vascular system while minimizing the risk of vessel trauma. Their adaptability to various angioplasty techniques makes them the preferred choice among healthcare professionals. In contrast, metal balloons represent an emerging segment, characterized by their strength and ability to withstand high pressures. Although they have a smaller market presence, their unique properties are leading to increased adoption in certain scenarios, particularly where durability is essential. The distinction between these materials is critical, as they cater to different clinical needs and influence procedural outcomes. ### By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the Angioplasty Balloons Market, hospitals represent the largest end-use segment, catering to a significant share of procedures due to their comprehensive facilities and specialized staffing. Ambulatory Surgical Centers (ASCs), although smaller in market share compared to hospitals, are quickly gaining traction, attributed to their efficiency and cost-effectiveness. The growth trends within this segment indicate a strong inclination towards minimally invasive procedures conducted in ASCs, which are seen as a more patient-centric approach. The increasing preference for outpatient services and technological advancements, such as improved balloon designs, are key factors driving the expansion of ASCs in the market. Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging) Hospitals continue to dominate the Angioplasty Balloons Market due to their extensive infrastructure, broader range of services, and 24/7 availability of healthcare professionals. They are well-equipped to handle complex cases and offer comprehensive post-procedure care, making them a preferred choice for critical interventions. On the other hand, Ambulatory Surgical Centers are emerging as a popular alternative owing to their focus on outpatient care, lower costs, and increased patient convenience. ASCs leverage advancements in medical technology and a streamlined approach to procedures, which appeals to a growing patient base opting for less invasive surgical options. This shift in preferences is reshaping the landscape of the angioplasty balloons market. ## Regional Market Share Analysis ### North America : Healthcare Innovation Leader. North America is the largest market for angioplasty balloons, holding approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on innovation. Regulatory support from agencies like the FDA facilitates rapid product approvals, enhancing market dynamics. The demand for minimally invasive procedures is also on the rise, further propelling market growth. The United States is the leading country in this region, with major players such as Boston Scientific, Medtronic, and Abbott Laboratories dominating the landscape via Abbott balloons. The competitive environment is characterized by continuous innovation and strategic partnerships among key players. Canada also contributes significantly to the market, focusing on improving healthcare access and patient outcomes, thereby supporting the overall growth of the cardiac balloons market. ### Europe : Emerging Regulatory Frameworks Europe is the second-largest market for cardiac balloons, accounting for approximately 30% of the global market share. The region benefits from a robust healthcare system and increasing investments in medical technology. Regulatory frameworks, such as the Medical Device Regulation (MDR), are evolving to ensure patient safety and product efficacy, which in turn drives market growth. The rising incidence of cardiovascular diseases and an aging population further fuel demand for angioplasty procedures. Leading countries in Europe include Germany, France, and the UK, where key players like B. Braun Melsungen AG and Cordis are actively involved. The competitive landscape is marked by innovation and collaboration among manufacturers to enhance product offerings. The presence of advanced research institutions also supports the development of cutting-edge technologies in the cardiac balloons market. ### Asia-Pacific : Rapidly Growing Market Asia-Pacific is witnessing rapid growth in the angioplasty balloons market, driven by increasing healthcare expenditure and a rising prevalence of cardiovascular diseases. The region holds approximately 20% of the global market share, with countries like Japan and China leading the charge. Government initiatives aimed at improving healthcare infrastructure and access to advanced medical technologies are significant growth drivers. The demand for minimally invasive procedures is also on the rise, contributing to market expansion. Japan is a key player in this market, with companies like Terumo Corporation and Asahi Intecc Co., Ltd. leading the way. The competitive landscape is characterized by a mix of local and international players, fostering innovation and collaboration. Additionally, the growing awareness of cardiovascular health among the population is expected to further boost the demand for angioplasty balloons in the region. ### Middle East and Africa : Untapped Market Potential The Middle East and Africa region is gradually emerging as a potential market for angioplasty balloons, holding approximately 5% of the global market share. The growth is driven by increasing healthcare investments and a rising prevalence of cardiovascular diseases. Governments are focusing on enhancing healthcare infrastructure and access to advanced medical technologies, which are crucial for market development. The demand for angioplasty procedures is expected to rise as awareness of cardiovascular health improves. Leading countries in this region include South Africa and the UAE, where healthcare reforms are paving the way for advanced medical solutions. The competitive landscape is still developing, with opportunities for both local and international players to enter the market. Key players are beginning to explore partnerships and collaborations to expand their reach in this untapped market. ## Competitive Benchmarking The Angioplasty Balloons Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Boston Scientific (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market positions. Boston Scientific (US) emphasizes the development of advanced balloon technologies, while Medtronic (US) is leveraging its extensive distribution network to penetrate emerging markets. Abbott Laboratories (US) appears to be concentrating on expanding its product portfolio through acquisitions, thereby enhancing its competitive edge in this rapidly evolving sector. In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure is moderately fragmented, with several key players exerting considerable influence. This fragmentation allows for a diverse range of products and innovations, fostering a competitive environment where companies must continuously adapt to maintain their market share. In August 2025, Boston Scientific (US) announced the launch of its latest drug-coated balloon, which is designed to improve patient outcomes in complex coronary interventions. This strategic move not only reinforces Boston Scientific's commitment to innovation but also positions the company to capture a larger share of the growing market for advanced angioplasty solutions. The introduction of this product is expected to enhance procedural efficiency and patient safety, thereby solidifying the company's reputation as a leader in the field. In September 2025, Medtronic (US) entered into a strategic partnership with a leading telehealth provider to integrate remote monitoring capabilities into its angioplasty balloon offerings. This collaboration aims to enhance patient engagement and streamline post-procedural care, reflecting a broader trend towards digital health solutions. By incorporating telehealth features, Medtronic (US) is likely to improve patient outcomes and satisfaction, which could translate into increased market share in the competitive landscape. In July 2025, Abbott Laboratories (US) completed the acquisition of a smaller medical device company specializing in innovative balloon technologies. This acquisition is indicative of Abbott's strategy to bolster its product offerings and expand its technological capabilities. By integrating these new technologies, Abbott Laboratories (US) is poised to enhance its competitive positioning and respond more effectively to the evolving needs of healthcare providers and patients. As of October 2025, the Angioplasty Balloons Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances are becoming increasingly important, as companies seek to leverage complementary strengths to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, supply chain reliability, and enhanced patient outcomes. This shift underscores the necessity for companies to invest in research and development to stay ahead in a market that is rapidly changing. ## Recent News & Developments Recent developments in the Angioplasty Balloons Market indicate a significant increase in demand driven by the rise in cardiovascular diseases globally. Companies like Medtronic Cardiovascular and Boston Scientific have been focusing on enhancing their product offerings to include advanced balloon technologies that improve patient outcomes. Notably, in September 2023, Abbott Laboratories announced the launch of a new line of drug-eluting balloons, aimed at providing more effective treatment options for patients suffering from coronary artery disease. Furthermore, a strategic merger was confirmed in August 2023, where Philips Healthcare acquired a small biotechnology firm specializing in innovative angioplasty balloon technologies, thereby augmenting its portfolio. Meanwhile, Asahi Intecc reported a steady growth in market valuation due to the increasing adoption of minimally invasive procedures, reflecting a broader industry trend aligning with healthcare advancements. In recent years, significant investments led by Johnson and Johnson and Cook Medical into Research and Development activities have aimed to drive innovation in angioplasty balloon designs, contributing to the overall market growth. These advancements and corporate strategies highlight the evolving landscape of the Angioplasty Balloons Market as companies look to capture market share through technological improvements and strategic collaborations. ## Report Scope | MARKET SIZE 2024 | 3.38(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 3.509(USD Billion) | | MARKET SIZE 2035 | 5.1(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.81% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Boston Scientific (US), Medtronic (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cordis (US), Terumo Corporation (JP), Asahi Intecc Co., Ltd. (JP), Cook Medical (US), AngioDynamics (US) | | Segments Covered | Types, Applications, Material, End Use, Regional | | Key Market Opportunities | Advancements in biodegradable materials enhance safety and efficacy in the Angioplasty Balloons Market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the angioplasty balloons market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the Angioplasty Balloons Market by 2035?** A: The projected market valuation of the Angioplasty Balloons Market is expected to reach 5.1 USD Billion by 2035. **Q: What was the overall market valuation of the Angioplasty Balloons Market in 2024?** A: The overall market valuation of the Angioplasty Balloons Market was 3.38 USD Billion in 2024. **Q: What is the expected CAGR for the Angioplasty Balloons Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Angioplasty Balloons Market during the forecast period 2025 - 2035 is 3.81%. **Q: Which segment is projected to have the highest valuation in the Angioplasty Balloons Market by 2035?** A: The Drug-Eluting Balloons segment is projected to reach a valuation of 2.0 USD Billion by 2035. **Q: What are the key applications of angioplasty balloons in the market?** A: The key applications include Coronary Angioplasty, Peripheral Angioplasty, and Renal Angioplasty, with Coronary Angioplasty projected to reach 2.45 USD Billion by 2035. **Q: Which materials are predominantly used in the production of angioplasty balloons?** A: The predominant materials include Polymer, Latex, and Metal, with Polymer expected to reach 2.0 USD Billion by 2035. **Q: What is the expected valuation of the Ambulatory Surgical Centers segment by 2035?** A: The Ambulatory Surgical Centers segment is expected to reach a valuation of 1.25 USD Billion by 2035. **Q: Who are the leading players in the Angioplasty Balloons Market?** A: The leading players in the Angioplasty Balloons Market include Boston Scientific, Medtronic, and Abbott Laboratories. **Q: What was the valuation of the Scoring Balloons segment in 2024?** A: The Scoring Balloons segment was valued at 1.03 USD Billion in 2024. **Q: How does the market for Plain Old Balloons compare to Drug-Eluting Balloons by 2035?** A: By 2035, the Plain Old Balloons segment is projected to reach 1.5 USD Billion, while Drug-Eluting Balloons is expected to reach 2.0 USD Billion. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/angioplasty-balloons-market-9614*